Can gut dysbiosis and constipation impair levothyroxine absorption?

The relationship between gastrointestinal health and thyroid function represents a complex, bidirectional axis where gut dysbiosis, small intestinal bacterial overgrowth (SIBO), and intestinal methanogen overgrowth (IMO) directly impact thyroid hormone replacement efficacy and micronutrient status.

Impact on levothyroxine absorption

• Direct mucosal disruption: SIBO, IMO, and dysbiosis alter mucosal transport proteins and increase intestinal permeability in the jejunum and upper ileum, leading to direct oxidative degradation of oral levothyroxine tablets and refractory hypothyroidism. Switching to liquid or soft-gel formulations significantly improves TSH control.
• Indirect effects of constipation: Slowed colonic transit does not directly impair absorption in the colon. However, common constipation therapies—such as calcium carbonate, magnesium- or aluminum-containing laxatives, and high-fiber supplements—physically bind levothyroxine in the upper gut, severely reducing its bioavailability.

Depletion of thyroid-supportive nutrients

• Microbial competition and transport damage: Overgrown microbes consume selenium for their own selenoproteins, depriving the host of a key cofactor needed for deiodinase enzymes to convert thyroxine (T4) to active triiodothyronine (T3).
• Impaired mucosal absorption: SIBO-induced mucosal inflammation and duodenal damage limit the absorption of zinc and iron (crucial for thyroid peroxidase activity). Additionally, bacterial deconjugation of bile acids impairs the absorption of fat-soluble Vitamin D.

The bidirectional gut-thyroid feedback loop

• Motility-driven stasis: Adequate levothyroxine levels normalize gastrointestinal transit time and the migrating motor complex. Conversely, untreated hypothyroidism slows gut motility, promoting the microbial stasis that perpetuates SIBO, IMO, and subsequent nutrient and hormone malabsorption.

Bottom line

• Gut dysbiosis, SIBO, and IMO directly impair levothyroxine absorption and deplete critical thyroid nutrients (selenium, zinc, iron), while hypothyroid-driven constipation promotes a cycle of microbial stasis. Resolving this feedback loop requires managing transit time, separating binding laxatives from thyroid medication, and potentially utilizing liquid hormone formulations.